Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Elizabeth G Davis"'
Publikováno v:
PLoS ONE, Vol 13, Iss 10, p e0206639 (2018)
Leptospirosis is a worldwide veterinary and public health concern, and well recognized infectious disease of horses. Seroprevalence rates vary with geography, but many studies have confirmed a high exposure rate. The correlation between seropositivit
Externí odkaz:
https://doaj.org/article/25626eb812ba47908adc91df657140f4
Publikováno v:
PLoS ONE, Vol 10, Iss 10, p e0140666 (2015)
Kansas witnessed an unprecedented outbreak in Corynebacterium pseudotuberculosis infection among horses, a disease commonly referred to as pigeon fever during fall 2012. Bayesian geostatistical models were developed to identify key environmental and
Externí odkaz:
https://doaj.org/article/80c26af122ec40448255df3efff12ac0
Autor:
Oded Marcovici, Winfred Arthur, Virginia T. Rentko, Elizabeth G. Davis, Scott A. Katzman, Jonathan Austin, Adam Birkenheur, Jonathan M. Levine, Elizabeth M. Hardie, Page E. Yaxley, Susan L. Fubini, Roger B. Fingland, Katherine L. Wells
Publikováno v:
Journal of Veterinary Medical Education. 48:528-532
The Veterinary Internship and Residency Matching Program (VIRMP) recently revised its electronic standardized letter of reference (SLOR) to improve the quality and usefulness of the data obtained from it and to enhance the relevance of non-cognitive
Publikováno v:
Journal of veterinary medical education. 49(6)
Expanding literature on well-being within veterinary medicine has been instrumental in recognizing the prevalence of psychological distress among students and practitioners, promoting awareness and advocacy for well-being within teaching institutions
Publikováno v:
Frontiers in Aging Neuroscience, Vol 6 (2014)
We used a lentiviral system for expressing secreted human Aβ in the brains of young and old APOE knock-in mice. This system allowed us to examine Aβ metabolism in vivo, and test the effects of both aging and APOE genotype, two of the strongest risk
Externí odkaz:
https://doaj.org/article/70d48df9425b4db187ff0dbc01118143
Publikováno v:
Equine Veterinary Education. 31:230-235
Summary A 7-year-old Quarter Horse mare was presented for severe left hindlimb oedema and nonweightbearing lameness that was progressive over approximately 48 h. The mare subsequently developed marked and worsening oedema, immune-mediated haemolytic
Publikováno v:
Equine Veterinary Education. 31:62-66
Summary A 16-year-old Quarter Horse gelding was presented to the Kansas State Veterinary Health Center for acute onset of diffuse, nonpruritic, generalised and coalescing urticaria. A single dose of dexamethasone resulted in resolution of the urticar
Publikováno v:
Journal of Veterinary Pharmacology and Therapeutics. 40:342-347
The primary study objective was to compare the pharmacokinetics of p.o. terbinafine alone to p.o. terbinafine administered with p.o. cimetidine in healthy adult horses. The second objective was to assess the pharmacokinetics of terbinafine when admin
Autor:
Arvind Kumar, Kara M. Lascola, Joy E. Tomlinson, Jeff Brakenhoff, Katie Delph, Randall W. Renshaw, Lisa E. Fultz, Edward J. Dubovi, Melissa Laverack, Bud C. Tennant, Amit Kapoor, Philip J. Johnson, Thomas J. Divers, Todd C. Holbrook, Elizabeth G. Davis, Rebecca E. Ruby, Sheetal Trivedi, Erica C. McKenzie, Gerlinde R. Van de Walle, Harold C. Schott, Jessica Carter‐Arnold, Emilie Setlakwe, Sandra D. Taylor, Laurie A. Beard
Publikováno v:
Journal of Veterinary Internal Medicine
Journal of Veterinary Internal Medicine, Vol 33, Iss 1, Pp 251-257 (2019)
Journal of Veterinary Internal Medicine, Vol 33, Iss 1, Pp 251-257 (2019)
Background Three flaviviruses (equine pegivirus [EPgV]; Theiler's disease-associated virus [TDAV]; non-primate hepacivirus [NPHV]) and equine parvovirus (EqPV-H) are present in equine blood products; the TDAV, NPHV, and EqPV-H have been suggested as
Publikováno v:
Equine Veterinary Journal. 47:667-674
SummaryReasons for performing study Protection from infectious disease requires antigen-specific immunity. In foals, most vaccine protocols are delayed until 6 months to avoid maternal antibody interference. Susceptibility to disease may exist prior